Drugs / Lugol's solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03180970 | Jun → Dec 2017 | esophagus carcinoma in situ | Shandong University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lugol's solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03180970 ↗ |
| Route | Topical | “1.2% Lugol's solution will be sprayed on the lesion suspected early esophageal squamous neoplasia .” NCT03180970 ↗ |